- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04604405
Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation
October 7, 2021 updated by: jun ren, Central South University
Effect of 650nm Low Energy Light on Macular Microcirculation in Myopia Prevention and Control
This project is a single-center, prospective, self-controlled clinical study.
It intends to select patients with simple medium and low degree myopia as subjects, and apply 650nm low-energy red light irradiation to the retina to observe its effect on macular microcirculation.
Study Overview
Detailed Description
A total of 120 subjects are planned to be recruited and divided into 4 groups according to age and intervention, including 30 in the juvenile intervention group, 30 in the juvenile control group, 30 in the adult intervention group and 30 in the adult control group.
Two intervention groups received 650nm low-energy red light irradiation treatment with a 650nm low-energy light emitter, twice a day for 3 minutes each time, The subjects were treated and followed up for 3 months.
The control group was not treated and followed up for 3 months too.
All subjects were followed up before treatment, at the end of the 1st month and at the end of 3rd month.
Angio-oct was used as the main examination to observe and record the vascular density and blood perfusion in macular area.
Axial length, diopter and OCT were used as secondary observation indexes.
At the end of the experiment, the data of the intervention group and the control group were compared
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 40000
- Chongqing Aier Eye Hosipital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 45 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age from 7 to 17 years old or from 18 to 45 years old;
- Meet the diagnostic criteria for patients with simple low or moderate myopia, with diopter < -6.0d and eye axis < 26.0mm;
- Transparent refractive stroma, no other eye diseases except nearsightedness;
- Agree to participate in the clinical study and sign the informed consent.
Exclusion Criteria:
- Other ocular lesions, such as uveitis, retinal/choroidal vascular lesions, congenital ocular lesions, glaucoma, high myopia (ocular axis > 26cm), degenerative retinal disease, optic neuropathy, etc.;
- Another eye with low vision
- Corneal edema/epithelial detachment, corneal opacity;
- Redness, pain, dry eye, photophobia, difficulty in opening eyes;
- Had a history of eye surgery in recent 3 months;
- Severe impairment of liver and kidney function and/or serious systemic diseases (such as cardiovascular, respiratory, digestive, nervous, endocrine, genitourinary, etc.);
- Women who are already pregnant, preparing for pregnancy during the study period and lactating;
- A history of substance abuse or alcohol abuse;
- Receiving prevention and control treatment for myopia other than glasses within the first 30 days;
- Any situation in which the study physician believes that the patient's condition will interfere with the clinical study (e.g., the patient is prone to nervous tension, uncontrollable emotions, depression, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: photobiomodulation
Eyes are irradiated with 650nm low energy red light
|
650nm low energy red light eye irradiation
|
No Intervention: blank
no intervention except for wear glasses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
retinal vascular density
Time Frame: 12 weeks
|
The vascular density of the inner retinal layer in the macular area within 3×3mm was measured by angio-OCT
|
12 weeks
|
retinal vascular perfusion
Time Frame: 12 weeks
|
The perfusion of the inner retinal layer in the macular area within 3×3mm was measured by angio-OCT
|
12 weeks
|
Choroid thickness
Time Frame: 12 weeks
|
Distance from Bruch membrane to The inner surface of the sclera
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Axial length
Time Frame: 12 weeks
|
Distance from corneal apex to macular fovea
|
12 weeks
|
diopter
Time Frame: 12 weeks
|
Myopic degree
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: yi wang, master, Doctoral supervisor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 8, 2020
Primary Completion (Actual)
October 9, 2020
Study Completion (Actual)
October 2, 2021
Study Registration Dates
First Submitted
October 15, 2020
First Submitted That Met QC Criteria
October 21, 2020
First Posted (Actual)
October 27, 2020
Study Record Updates
Last Update Posted (Actual)
October 15, 2021
Last Update Submitted That Met QC Criteria
October 7, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- cq-wy-pbm-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on photobiomodulation
-
University of Nove de JulhoNot yet recruitingPostmenopausal Symptoms
-
University of Nove de JulhoNot yet recruiting
-
University of Nove de JulhoUnknownSoft Tissue Injuries
-
University of Nove de JulhoCompletedTemporomandibular DisordersBrazil
-
University of Nove de JulhoUnknownTemporomandibular DisorderBrazil
-
Quietmind FoundationMaculume Ltd.Completed
-
University of Nove de JulhoNot yet recruitingPhotobiomodulation | Dental HypersensitivityBrazil
-
University of Nove de JulhoNot yet recruiting
-
University of Nove de JulhoRecruiting
-
University of Nove de JulhoRecruiting